Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Piperazine Ferulate

    • Product Name Piperazine Ferulate
    • Alias Piperyl Ferulate
    • Einecs 221-006-7
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    421513

    Generic Name Piperazine Ferulate
    Chemical Formula C10H14N2O4
    Molecular Weight 226.23 g/mol
    Appearance White to off-white crystalline powder
    Solubility Soluble in water
    Cas Number 53179-13-8
    Usage Mainly used in the management of chronic glomerulonephritis
    Route Of Administration Oral
    Storage Conditions Store in a cool, dry place away from light
    Mechanism Of Action Improves microcirculation and inhibits platelet aggregation

    As an accredited Piperazine Ferulate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Piperazine Ferulate is packaged in a white, sealed plastic bottle containing 100 tablets, labeled with dosage and manufacturer information.
    Shipping Piperazine Ferulate is shipped in tightly sealed containers, protected from light and moisture. Packages comply with relevant chemical safety regulations, labeled with hazard information if applicable. During transit, temperature control and secure handling are ensured to prevent contamination or degradation, following standard protocol for pharmaceutical intermediates or research chemicals.
    Storage Piperazine Ferulate should be stored in a tightly closed container, protected from light, moisture, and excessive heat. Store it in a cool, dry, and well-ventilated area, away from incompatible substances such as strong oxidizers. Maintain storage temperatures between 2°C and 8°C (refrigerated) if specified by the manufacturer. Proper labeling and segregation as per chemical safety regulations are recommended.
    Application of Piperazine Ferulate

    Applications of Piperazine Ferulate in Industrial Manufacturing

    Piperazine Ferulate serves distinct functions as an active ingredient or intermediate in several industrial sectors, notably within pharmaceutical and intermediate manufacturing. Our production supports trusted downstream applications, with strict attention to regulatory and quality compliance, process integration, and real-world customer formulation needs.

    1. Cardiovascular Active Pharmaceutical Ingredient (API) Manufacturing

    Pharmaceutical companies incorporate this material as a core intermediate or direct API for formulations intended to address vascular and circulatory health. Its utility in this field is tightly regulated, and every batch must undergo rigorous quality assurance at several manufacturing checkpoints. Teams develop drug products using controlled crystallization, with solvent management protocols ensuring the compound's purity and stability during tablet and capsule composition. End users rely on this product for manufacturing medications that improve peripheral blood circulation and reduce thrombosis risk.

    Industry compliance standards

    • Chinese Pharmacopoeia (ChP) current edition for API quality attributes
    • Good Manufacturing Practice (GMP, National Medical Products Administration - NMPA)
    • European Pharmacopoeia (Ph. Eur.) and United States Pharmacopeia (USP) where product is exported to regulated markets
    • ICH Q7 and Q8 guidelines for API production and documentation standards

    Typical usage ratio

    • Formulators generally use 50–100 mg per oral solid dose, with batch API loading at 7–15% by mass, depending on targeted patient population and dosage form release profile; final content is adjusted according to regulatory-approved monograph specifications.

    Downstream process integration

    • Introduced during the blending phase of direct compression and wet granulation lines
    • Integrated at the pre-tableting stage for pellet, tablet, and capsule manufacturing
    • QC sampling at post-milling and pre-coating to verify assay, purity, and particle characteristics
    • Traceable through in-line and end-product batch release according to validation protocols

    Final product types

    • Finished prescription drugs for vascular circulation improvement
    • Fixed-dose combination tablets with complementary cardiovascular agents
    • Oral capsules targeting venous thromboembolism prophylaxis
    • Pilot-scale R&D batches for clinical and post-market surveillance studies

    2. API Intermediate Synthesis for Custom Drug Development

    Custom pharmaceutical process development and contract manufacturing organizations incorporate Piperazine Ferulate as a key intermediate during route selection for several synthetic APIs. Its reactivity and functional group tolerance enable multiple-step coupling and protection-deprotection sequences within closed reactor trains. Each process environment requires precise control of temperature and solvent to avoid by-product formation, with real-time HPLC monitoring of intermediate stages. Final isolated intermediates become building blocks in complex drug synthesis programs, particularly for new investigational compounds under patent protection.

    Industry compliance standards

    • GMP for Intermediates (China, EU, and US guidelines)
    • Synthetic pathway documentation per ICH Q11 (Development and Manufacture of Drug Substances)
    • Hazard and critical process control points as outlined by ISO 9001:2015 (where relevant for API intermediates)
    • Chemical safety reporting compliant with REACH (for shipments within or to the European Union)

    Typical usage ratio

    • Pilot groups employ batch or fed-batch rates of 0.8–2.5 mol equivalents in one or more reaction steps, with actual input quantity based on targeted yield, step conversion, and impurity profile management.

    Downstream process integration

    • Charged into high-shear reactors after solvent preconditioning
    • Sequential addition for nucleophilic substitution or salt formation
    • Processed through liquid–liquid extraction and crystallization stages
    • Tracked via in-process controls (IPCs) and intermediate release specifications

    Final product types

    • Custom synthesized API intermediates
    • Protected and deprotected building blocks for further API chain elongation
    • Modified lead compounds for investigational new drug (IND) candidate libraries
    • Intermediate salts supplied to CDMO and CMO partners

    3. Finished Injectable Formulation Production

    Sterile drug formulation producers source this compound for parenteral product assembly, particularly where fast systemic absorption is required in vascular or anti-thrombotic therapies. Process teams operate in controlled, aseptic environments, ensuring thorough solubilization and sterile filtration prior to lyophilization or aseptic filling. Operators must verify heavy metal and endotoxin levels at multiple checkpoints, and terminal manufacture uses validated sterilization techniques. Output batches contribute to injectable finished goods delivered directly to hospital, clinic, or pharmacy channels.

    Industry compliance standards

    • China GMP and EU GMP Part I/II (sterile manufacturing)
    • Guidelines for parenteral preparation—Chinese Pharmacopoeia (ChP), USP <797>, and Ph. Eur.
    • ISO 14644-1 cleanroom classifications for aseptic preparation areas
    • Compendial criteria for API/Excipent purity and absence of pyrogens

    Typical usage ratio

    • Injectable solutions generally formulated at 10–50 mg/mL, with precise adjustment for total volume and dose delivery form (single- or multi-dose vials, ampoules), based on clinical and regulatory requirements. Formulators adapt for patient weight-based dosing as needed.

    Downstream process integration

    • Prepared in sterile compounding rooms after dissolution in water-for-injection (WFI)
    • Quality-checked by HPLC assay and tested for microbial contamination at intermediate fill stages
    • Subjected to terminal sterilization (autoclave or filtration) before final container closure
    • Batch release conditional on sterility and stability data compliance

    Final product types

    • Intravenous (IV) injectable solutions for hospitals
    • Pre-filled syringe kits supplied to clinical centers
    • Ampoules and large-volume parenteral formulations
    • Emergency therapeutic packs for acute cardiovascular intervention

    4. R&D Reference Material Supply for Pharmaceutical Analytical Laboratories

    Quality control and research divisions at pharmaceutical companies and laboratory service organizations require high-purity reference-grade material to support method validation, calibration, and routine release testing. Sourcing standards are produced under stringent isolation and documentation controls to guarantee batch traceability and analytical reliability. Laboratories integrate this raw material into HPLC, UV-Vis, and mass spectrometry protocols to confirm finished product assay, identity, and impurity content during every production cycle.

    Industry compliance standards

    • Reference Standard certification per ChP, USP, and Ph. Eur. protocols
    • ISO/IEC 17025:2017 for testing and calibration laboratories
    • FDA 21 CFR Part 211 for Analytical Test Records
    • Good Laboratory Practice (GLP) guidelines for handling and documentation

    Typical usage ratio

    • Reference standards used at microgram to milligram concentration levels, typically ranging 0.1–10 mg per analytical run; weight is standardized for calibration and spiking, not for bulk formulation.

    Downstream process integration

    • Direct use in preparation of analytical calibration curves
    • Spiking protocols for accuracy, precision, and linearity assessments
    • Documentation for method validation, system suitability, and test result reconciliation
    • Archived under controlled storage conditions for audit trails and retesting

    Final product types

    • Certified and documented reference standard vials for QC
    • Analytical kits for stability studies and batch release
    • On-site reagents for research and regulatory filing support
    • Third-party laboratory proficiency testing lots
    Free Quote

    Competitive Piperazine Ferulate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Piperazine Ferulate: A Closer Look at Production, Application, and Value

    Introduction to Piperazine Ferulate: Real-World Lessons from Our Factory Floor

    Long days on the production line have taught me you can truly know a chemical only after you’ve handled it through each stage of synthesis and witnessed its transformation from raw material to finished product. Piperazine Ferulate, as an active pharmaceutical ingredient, has a reputation built on both its chemistry and its impact in real medical practice. Through years behind the reactors and drying ovens, we’ve watched this compound improve with every adjustment to our process, and the results speak for themselves in both quality and usability for solid dosage forms.

    Product Overview—A Manufacturer’s Perspective

    Piperazine Ferulate doesn’t come out of thin air. The synthesis involves coupling piperazine, an organic base, with ferulic acid—a compound well-known among botanists for its presence in plants like rice bran and oats. You want these two elements to combine completely, which requires fine-tuned reaction conditions and scrupulous purification. Poor process control means higher impurity levels, something we target carefully, since even trace contamination can challenge tablet manufacture or, worse, clinical outcomes. Years of adjusting reaction temps and solvent ratios have landed us on a process that gives consistent purity, which matters during regulatory scrutiny and when pharmacists run their own incoming QA.

    In our facility, Piperazine Ferulate is produced mainly in the form of a white or off-white crystalline powder. We pride ourselves on a batch-to-batch purity that typically hits over 99% HPLC, with tight controls on heavy metals and residual solvents. Moisture content isn’t just a lab reading for us—it has direct consequences on downstream tablet formulation. Our technical team checks every lot for loss on drying to keep tabletting predictable and storage problems at bay. Too much moisture and tablets chip; too little, and they crumble before they make it past the tablet press.

    Getting the Details Right: Specifications That Actually Matter

    Clients often ask us about appearance, assay range, and microbial limits. These details aren’t just boilerplate—they’ve come from years of government registration, customer experience, and patient safety. For us, a slight variance in crystallinity directly influences how the product compresses. Since regulatory filings demand consistent analytical profiles, even minor differences in IR spectra or melting points become critical, not just for legal peace of mind, but for downstream process engineers who can’t afford surprises on the tablet line.

    Sterility isn’t usually a focus for substances like Piperazine Ferulate, intended for oral administration, but we still push for low bioburden. No one wants to find out a product line needs halting because of an unexpected bacterial count. Our micro department knows the drill—each day starts with a battery of tests, and out-of-limit results mean a hard look at utility water systems or air handling, not just a report sent up the chain.

    Practical Use in the Pharmaceutical World

    Piperazine Ferulate carries a specific role in drug manufacturing, largely as a raw material for oral dosage formulations. Its mechanism in clinical settings centers on improving blood microcirculation and providing anti-inflammatory effects, which, over the years, have found a home in prescriptions for chronic hepatitis and vascular issues. Every time a client calls about tabletting or encapsulation concerns, it’s clear that the grade and consistency of Piperazine Ferulate make or break production schedules. Uniform flow and predictable compressibility are results we chase with every process tweak, and feedback from partners tells us these efforts are felt on the pharmacy side.

    We’ve witnessed batches pass through other companies’ wet granulation lines, dry mixing setups, and various encapsulation machines. Subtle changes in particle size distribution can affect blend uniformity and, eventually, dose accuracy. In those cases, a phone call and a shipped sample later, our R&D shifts gears, making fine adjustments to mesh size or recalibrating the milling step. When clients face solubility hurdles in formulation, our chemists work directly alongside theirs, running dissolution tests until the right release curve shows up on the graph. This ongoing conversation between producer and end-user has turned out better products for everyone involved.

    Comparing Piperazine Ferulate with Other Ingredients on the Market

    The pharmaceutical industry offers many actives and excipients, and not all have the same demands for purity or consistency. Products like ascorbic acid or paracetamol have their own challenges—often volume-based, with huge lots for OTC market needs. Piperazine Ferulate stands apart not in the sheer scale, but in its more specialized medical focus and a regulatory landscape that refuses shortcuts.

    Most customers coming to us for Piperazine Ferulate don’t mistake it for industrial chemicals or broad-spectrum actives. In production, we can see the difference in cost per batch and the high level of analytical attention from clients. Oversights lead to rapid regulatory feedback or production stoppages on the client’s side, something we’re keen to avoid with careful process validation. Unlike many low-cost, high-volume chemicals, the value in our process often comes down to traceability—being able to show which reactor batch made the powder, which staff performed the filtration, and how the audit trail reads for every single kilo.

    Even among alternative products for similar vascular or liver conditions—substances like glycyrrhizin or some synthetic hepatoprotectives—the comparison quickly comes back to side-effect profiles, ease of formulation, and history of clinical outcomes. Piperazine Ferulate balances a recognized safety record with real-world success in chronic cases, which makes up for its more niche production and handling requirements.

    Process Challenges That Shape the Product

    Bringing a batch of Piperazine Ferulate through production keeps our teams sharp. Scaling up from bench to pilot plant revealed points where a careless operator could spike impurity levels—particularly during the esterification step. We lost more than a few batches in the early days to over-reaction, incomplete neutralization, or contamination. In the years since, we’ve hardened our process checks, rooted out weak spots in cleaning validation, and invested in better real-time analytics.

    Solvent recovery and waste minimization also play a greater role than clients might expect. Regulatory and environmental pressure means stricter tracking of effluent streams and air discharges. With every improvement to solvent recycling, we’ve clipped overhead while cutting our environmental impact—a win for the community and for the folks running the drum dryers. Our technical team runs pilot tests on every process tweak before full-scale rollout, not just for regulatory box-ticking, but because a single oversight has knock-on effects: production delays, lost yield, or worse, out-of-spec product that leaves our warehouse headed back to reprocessing.

    Safety and Worker Experience

    On the factory floor, attention to detail around Piperazine Ferulate isn’t limited to QC paperwork. Proper handling keeps everyone safe—and our people know that real hazards come from repeated exposure as much as single spills. Training includes not only respirator use and engineering controls but also hands-on discipline with every batch transfer. We’ve engineered hoppers and enclosed transfer lines after seeing what fine dusting can do after a long shift. Our staff provides valuable feedback during every production improvement—not just for process efficiency but for ergonomic gains and overall job satisfaction.

    Documentation is another area shaped largely by worker experience. The checks aren’t just for auditors; they help shift supervisors spot problems before the batch gets too far to fix. By involving operators in root cause analyses, we’ve created a culture where process improvements stick, because people on the floor understand not just the what but the why.

    Supply Chain Realities and Traceability

    Just as our raw material shipments rely on weather, customs policy, and supplier performance, so too do our deliveries to customers. Over the past decade, clients have sharpened their focus on traceability—an area where the best-intentioned documentation can falter without good digital infrastructure. We’ve upgraded our batch tracking, labeling, and digital records not only to satisfy short-notice inspections, but also to give peace of mind to clients who run frequent audits of their own.

    Alex, our supply chain manager, describes tracking a lot from arrival at the receiving dock to final packing: every handoff, every test, every change in storage condition logged. This depth of traceability doesn’t just guard against recalls; it helps us spot issues before they get down the line, whether it’s an inconsistency in raw material assay or a hint of deviation in drying conditions.

    Learning from Real Challenges—Supporting the Industry

    We’ve weathered global supply swings for solvents and reagents—experiences that taught us to keep a wider base of approved suppliers and tighter control over inventory levels. More than once, ship delays or border slowdowns put stress on our schedules. Rather than passing inconvenience to our customers, we invested in better forecasting and extra buffer stock, prioritizing product quality over temporary price breaks. Every surge in demand pushes our production crew to their limit, and every lull tests our cost control discipline, but neither challenge overshadows our core commitment: get Piperazine Ferulate to our clients on time, in spec, without drama.

    Our technical support often goes beyond mere problem solving. We share knowledge about stability studies, changes in pharmacopeia requirements, and issues arising from new excipient interactions. Clients in formulation get more than a certificate of analysis; they receive our insights earned over years of seeing Piperazine Ferulate behave in actual drug products. This practical wisdom, more than just chemical data, keeps development costs in check and timelines on track.

    Why Purity and Consistency Matter So Much

    Handling Piperazine Ferulate through the entire value chain reveals problems another industry might miss. Regulatory files demand explanation for every blip in purity or deviation in elemental impurities, and we know excipients and other APIs often have more tolerance. Failures in homogeneity or out-of-range values in handover reports trigger rapid review cycles—teams mobilize, records are scoured, and root causes are unearthed, often leading back to a single miscalibrated sensor or erroneous weighing.

    These lessons shape the trust between manufacturer and partner. When a pharmaceutical company comes to us needing a new lot for an upscaled production run, they don’t just want milligrams—they need certainty. Anything less than full disclosure and a willingness to troubleshoot face-to-face won’t satisfy regulatory authorities or support safe, reliable medicines for patients. The value comes not from the molecule, but from the years of control over every possible variable.

    Supporting Pharmaceutical Progress with a Reliable Partner

    The trend in the pharmaceutical world leans toward more scrutiny and greater complexity for every component in a finished drug. Piperazine Ferulate’s position depends not just on its chemistry, but on how smoothly it integrates into a formulation and how painlessly it passes regulatory review. Over the years, successful collaboration with R&D teams has let us anticipate common hurdles—such as incompatibility with certain fillers, or challenges in achieving desired dissolution rates in sustained-release tablets.

    We’ve supported process optimization on the client side by making minor adjustments on ours, such as shifting particle size distribution or revalidating a drying method. This back-and-forth between manufacturing and formulation helps both sides avoid costly missteps during new product launches. Information does not flow just one way; insights returned from client experience get channeled right back into our process design.

    The Environmental and Social Footprint

    For those of us actually making Piperazine Ferulate, sustainability is a daily, hands-on task, not just a thing for annual reports. Reducing energy use means assessing every heat exchanger and drier, not only out of environmental obligation, but because our energy bills reflect every inefficiency. Solvent recovery isn’t theoretical—we run distillation columns daily, tracking yield losses and emissions to the decimal.

    Waste neutralization follows strict rules, and our teams draw from field experience when implementing new treatment systems. Where possible, we source renewable energy or make use of waste heat in neighboring processes. Every improvement comes from small, practical decisions, accumulated over time rather than big declarations. Community and worker safety get the same attention; we know that every drum and every vented liter of air connects our plant to the world outside, and we act with that knowledge each day.

    The Human Side—People Behind the Product

    Years of manufacturing Piperazine Ferulate mean familiarity with every odd batch, every unexpected outage, every triumphant process improvement. What keeps progress moving is a crew of talented people, from line operators checking crystal formation under a microscope to QC analysts running HPLC assays night and day. The product’s reputation rides on each person doing their job right—and holding each other accountable to high standards.

    Seasoned workers remember which valve sticks, which cooling loop needs watching in the summertime, and which early-morning delivery to expect in bad weather. Training passes from veteran to rookie, and pride in a clean, issue-free batch sharpens with each cycle. Those relationships form the backbone of our ability to respond quickly, improve processes, and deliver consistently.

    Future Directions—Staying Ahead with R&D and Industry Trends

    Pharmaceutical demands change with new medical findings, shifting regulations, and production economics. As a manufacturer, we keep watch on evolving compendia requirements, novel delivery forms, and even new indications under clinical research. Continuous process improvement—be it better catalysts, greener solvents, or smarter analytical methods—remains part of our daily mindset.

    Feedback from medical experts and formulation scientists drives us to trial improvements, run validation batches, and share insights through joint development projects. Rather than resting on past achievements, we put resources into R&D and foster direct conversations with formulation partners. It’s in these collaborations—solving real problems for real drug developers—that Piperazine Ferulate maintains a relevant, effective place in pharmaceutical manufacturing.

    Conclusion: Piperazine Ferulate as More Than Just a Chemical

    What distinguishes Piperazine Ferulate from other pharmaceutical ingredients? More than formula or purity, it’s the cumulative experience embedded in every kilogram shipped from our plant. Long-term trust with clients, a culture of problem-solving, and persistent attention to health, safety, and environmental impact represent the true value of our work.

    By treating each batch as part of a bigger picture—where quality and responsibility walk together—we continue delivering a product that health professionals trust and patients depend on. Working with Piperazine Ferulate teaches a lesson all chemical manufacturers know: real value grows with every year of steady hands, open communication, and the shared goal of reliable, safe medicine.